Publication | Open Access

Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study

Retrospective StudyAnti-pd-1 TherapyMedicineGynecologyCancer TreatmentOncologyRadiation OncologyHigh-risk Chemorefractory